Skip to content

Energy Dense Oleic Acid Formula to Geriatric Patients

Energy Dense Oleic Acid Rich Formula to Newly Admitted Geriatric Patients - Feasibility and Effects on Energy Intake

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01042340
Enrollment
71
Registered
2010-01-05
Start date
2005-12-31
Completion date
2007-07-31
Last updated
2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Intervention

Keywords

nutrition, geriatric, supplement, energy

Brief summary

Background and aims: Old patients seldom reach energy requirements. The effects of an oleic-acid rich formula on energy intake and appetite were studied. Methods: Recently admitted geriatric patients (n=71), likely to stay more than 1 week were randomised to receive a fat emulsion (Calogen, intervention group (IG)) or to standard care (control group (CG)). Thirty ml of the emulsion were given 3 times daily, i.e. 420 kcal, and was distributed at the regular medication rounds. Food intake and self-rated appetite were registered 2-3 days after admission and on day 8 or the day prior to discharge. Nutritional risk screening (NRS) 2002 and serum lipids and fatty acid profiles were analysed.

Interventions

OTHERCalogen® - an energy dense oleic acid based formula

A daily dose of 3 x 30 ml of Calogen®, strawberry flavour, distributed at the same time as the pharmaceutical prescriptions, i.e. at 7.00, 14.00 and 20.00.

Sponsors

Karolinska Institutet
CollaboratorOTHER
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria were: likely to stay at the ward more than one week, \>65 years old and able to give informed consent.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frame
To detect a significant difference in energy intake of 48kJ/200 kcal between the groups at 5% significance level and with 80% power.5 days to 3 weeks intervention

Secondary

MeasureTime frame
Effects on serum lipids and appetite5 days to 3 weeks treatment

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026